Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Dacarbazine in Soft Tissue Sarcoma
NCT00837148Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2009
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in leiomyosarcoma (LMS), synovial sarcoma (SS), malignant peripheral nerve sheath tumor (MPNST), sponsored by Memorial Sloan Kettering Cancer Center. Started Feb 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
leiomyosarcoma (LMS)synovial sarcoma (SS)malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT00837148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837148.